Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Clinical trial NCT04778553 · COMPLETED

Trial details

NCT number: NCT04778553
Sponsor: Essenlix Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Hematologic Tests

Start date: 2020-10-19
Primary completion: 2020-12-09
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.